Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression in Parkinson's Disease.

Richard1

  • 1University of Rochester, Movement Disorder Unit, 601 Elmwood Avenue, Box 673, Rochester, NY 14642, USA. richard@etin.mct.rochester.edu

Current Treatment Options in Neurology
|November 30, 2000
PubMed
Summary

Depression is common in Parkinson's disease (PD), but diagnosis is challenging due to overlapping symptoms. Treatment involves antidepressants like sertraline or paroxetine, psychotherapy, and regular follow-ups.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On Extirpation of Fistula in Ano.

Western journal of medicine and surgery·2024
Same author

Medical problems for the troop commander.

Militarsanitat·2010
Same author

Amyotrophic lateral sclerosis with perepetular involvement.

Lyon medical·2010
Same author

Advances in detection methods for fungal and algal toxins.

Natural toxins·2000
Same author

Measurement of ingestion rate of Hydrobia ulvae (Pennant) on intertidal epipelic microalgae: the effect of mud snail density.

Journal of experimental marine biology and ecology·2000
Same author

Microstructure of Cu(x)Mo6S8 Chevrel phase thin films on R-plane sapphire

Journal of electron microscopy·2000

Area of Science:

  • Neurology
  • Psychiatry
  • Pharmacology

Background:

  • Depression is a frequent comorbidity in Parkinson's disease (PD), presenting diagnostic challenges due to symptom overlap with motor and non-motor PD features.
  • Symptoms like fatigue, sleep disturbances, and reduced affect can be manifestations of PD itself, complicating the accurate identification of depression.
  • Apathy, while potentially linked to depression, can also occur independently and may be associated with cognitive impairment in PD patients.

Purpose of the Study:

  • To outline diagnostic considerations for depression in Parkinson's disease, emphasizing psychological symptoms.
  • To provide guidance on pharmacological and non-pharmacological treatment strategies for depression in PD.
  • To highlight the importance of differentiating depression from other PD-related symptoms and managing it as a distinct condition.

Main Methods:

  • Focus on evaluating subjective psychological experiences such as sadness and anhedonia for diagnosing depression in PD.
  • Discusses the use of selective serotonin reuptake inhibitors (SSRIs) like sertraline and paroxetine as first-line antidepressants.
  • Considers alternative treatments including nortriptyline, pramipexole, psychotherapy, and electroconvulsive therapy for severe cases.

Main Results:

  • SSRIs are recommended, with caution advised regarding potential motor side effects, necessitating close monitoring.
  • Nortriptyline is suggested as a second-line option due to a favorable side effect profile compared to other tricyclic antidepressants.
  • Pramipexole may offer mood benefits in mild depression, though evidence is limited; long-term antidepressant therapy (≥6 months) is generally advised.

Conclusions:

  • Depression in Parkinson's disease requires specific diagnosis and treatment, distinct from motor symptoms.
  • A stepwise approach to pharmacotherapy, starting with SSRIs and considering alternatives, is effective.
  • Psychological support, regular follow-up, and consideration of psychiatric referral for severe cases are crucial for managing depression in PD.

Related Experiment Videos